Cephalon, Inc. v. Watson Pharmaceuticals, Inc.

Procedural entryThis page is a short order in Cephalon, Inc. v. Watson Pharmaceuticals, Inc.. Read the opinion of the Court — 707 F.3d 1330
Court of Appeals for the Federal Circuit·Decided July 13, 2012·No. 2011-1325·Unpublished

Opinion

NOTE: This order is nonprecedential

United States Court of Appeals for the Federal Circuit

CEPHALON, INC. AND CIMA LABS, INC., Plaintiffs-Appellants,

V.

WATSON PHARMACEUTICALS, INC., WATSON LABORATORIES, INC., AND WATSON PHARMA, INC., Defendants-Appellees.

2011-1325

Appeal from the United States District Court for the

District of Delaware in case no. 08-CV-0330, Judge Sue L. Robinson.

ON MOTION

O R D E R Cephalon, Inc. and CIMA Labs, Inc., move for a 30-

day extension of time, until August 6, 2012, to file their reply brief due to settlement negotiations.

Upon consideration thereof,

IT IS ORDERED THAT:

CEPHALON V. WATSON PHARMA

The motion is granted.

JUL 1 3 2012

Date

ccc William F. Lee, Esq.

J ames K. Stronski, Esq.

FoR THE CoURT

/s/ Jan Horbal Jan Horbaly Clerk

ga F°“

nmsensnn.ic:acurr JUL 1 3 ZU"|Z JANHURBALY CLEBK

Free access — add to your briefcase to read the full text and ask questions with AI

Cephalon, Inc. v. Watson Pharmaceuticals, Inc., (Fed. Cir. 2012).

Cephalon, Inc. v. Watson Pharmaceuticals, Inc. (Cephalon, Inc. v. Watson Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.